BIOMAT Database Logo BIOMAT Database Logo

[Long-term remission after treatment of primary amyloidosis with azathioprine]. 1980

Z Plamieniak, and E Zareba-Bogdał, and W Bednorz

UI MeSH Term Description Entries
D008297 Male Males
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?
April 2007, Inflammatory bowel diseases,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
October 1995, The New England journal of medicine,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
April 2012, The Journal of clinical endocrinology and metabolism,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
Long-term treatment of multiple sclerosis with azathioprine.
February 1973, Journal of neurology, neurosurgery, and psychiatry,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
[Long-term treatment of rheumatoid arthritis with azathioprine].
January 1977, La Clinica terapeutica,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
Long term treatment of myasthenia gravis with azathioprine.
February 1990, Postgraduate medical journal,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
[Long-term remission of amyloidosis complicating fibrocavernous pulmonary tuberculosis].
August 1968, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
[Hematological remission of primary myelofibrosis with antiphospholipid antibody following treatment of azathioprine].
February 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
July 2002, Alimentary pharmacology & therapeutics,
Z Plamieniak, and E Zareba-Bogdał, and W Bednorz
[Long-term remission of the nephrotic syndrome in renal amyloidosis].
January 1986, Terapevticheskii arkhiv,
Copied contents to your clipboard!